This inventor holds 2 USPTO granted patents. Top assignees: Gsf-Forschungszentrum Fur Umwelt Und Gesundheit, Gmbh, Helmholtz Zentrum Munchen Deutsches Forschungszentrum Fur Gesundheit Und Umwelt. Active years: 2006-2011.
Company Filing History:
1 out of 40 
1 out of 94 
Years Active: 2006-2011
Title: Georg Bornkamm: Innovator in Immunization Methods
Introduction
Georg Bornkamm is a notable inventor based in Munich, Germany. He has made significant contributions to the field of immunization, particularly through his innovative methods involving bispecific and trispecific antibodies. With a total of two patents to his name, Bornkamm's work has the potential to impact both human and animal health.
Latest Patents
Bornkamm's latest patents include a method for ex vivo immunization using heterologous intact bispecific and/or trispecific antibodies. This invention describes a comprehensive approach for ex vivo immunization of humans and animals, outlining specific steps to enhance the effectiveness of immunization processes.
Career Highlights
Throughout his career, Georg Bornkamm has worked with prominent research institutions. He has been associated with the GSF-Forschungszentrum für Umwelt und Gesundheit GmbH and the Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH. His work in these organizations has allowed him to advance his research and contribute to significant scientific advancements.
Collaborations
Bornkamm has collaborated with esteemed colleagues, including Horst Lindhofer and Hans-Joachim Kolb. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of immunization.
Conclusion
Georg Bornkamm's contributions to immunization methods through his patents and collaborations highlight his role as an influential inventor in the scientific community. His work continues to pave the way for advancements in health and immunization strategies.